G protein–coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis
article
OA: closed
CC0
⤵ 16 in-corpus citations
AI-generated summary
The G protein-coupled estrogen receptor 1 agonist G-1 was found to induce cell cycle arrest in the mitotic phase, ultimately leading to apoptosis in endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo demonstrate the effects of the selective G protein-coupled estrogen receptor 1 (GPER) agonist G-1 in human ovarian endometriotic stromal cells (ESCs).DesignExperimental in vitro study.SettingUniversity hospital.Patient(s)A total of 33 patients with ovarian endometrioma.Intervention(s)Endometriotic stromal cells from ovarian chocolate cysts were treated with the GPER agonist G-1.Main outcome measure(s)The primary outcomes were cell proliferation, measured using the WST-8 assay; cell cycle, as analyzed using flow cytometry, fluorescent immunocytochemistry, and cytotoxicity; caspase activity, as measured by fluorescent and luminescent enzyme assays; and protein expression levels, as determined by Western blot analysis.Result(s)G-1 suppressed ESC proliferation in a concentration-dependent manner. The inhibitory effect was not blocked when GPER signaling pathways, including the GPER itself, were inhibited. G-1 induced cell cycle arrest and accumulation in the sub-G1 phase in ESCs. Immunofluorescence analysis demonstrated that G-1 interrupted microtubule assembly at the mitotic phase. G-1 also induced caspase-3-dependent apoptosis without significant cytotoxicity.Conclusion(s)G-1 suppressed proliferation and induced apoptosis in ESCs, suggesting the potential use of this compound as a therapeutic drug for the treatment of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro via openalex
- Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis via openalex
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture via openalex
- Endometriotic cells are resistant to interferon-γ-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis via openalex
- Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis via openalex
- Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study via openalex
- G Protein-Coupled Estrogen Receptor (GPER) Expression in Normal and Abnormal Endometrium via openalex
- Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells via openalex
- Increased Activation of the PI3K/AKT Pathway Compromises Decidualization of Stromal Cells from Endometriosis via openalex
- Protein kinase inhibitors can control the progression of endometriosis <i>in vitro</i> and <i>in vivo</i> via openalex
- Puerarin Suppresses Proliferation of Endometriotic Stromal Cells Partly via the MAPK Signaling Pathway Induced by 17ß-estradiol-BSA via openalex
- Role of Estrogen Receptor-β in Endometriosis via openalex
- The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis via openalex
- Transmembrane Estrogen Receptor GPR30 is More Frequently Expressed in Malignant Than Benign Ovarian Endometriotic Cysts and Correlates With MMP-9 Expression via openalex
- W2076908209 via openalex
- W2083063093 via openalex
- W2087393969 via openalex
- W2103019385 via openalex
- W2107497260 via openalex
- W2109801386 via openalex
- W2122880493 via openalex
- W2148764267 via openalex
- W2149713530 via openalex
- W2168113107 via openalex
- W2317926428 via openalex
- W4211081176 via openalex
- W1662899239 via openalex
- W6637923212 via openalex
- W1789883744 via openalex
- W1964904672 via openalex
- W1965080988 via openalex
- W1980748988 via openalex
- W1983349129 via openalex
- W1988769211 via openalex
- W1997046615 via openalex
- W1999672543 via openalex
- W2025138095 via openalex
- W2042358762 via openalex
- W2064580048 via openalex
- W2069561389 via openalex
- W2075443461 via openalex
Cited by (17)
- A multicenter randomized placebo-controlled trial evaluating daidzein-rich isoflavone aglycones in endometriosis-associated dysmenorrhea 2026
- Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies 2025
- The "Road" to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review 2024
- Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway 2024
- Evaluation of survivin expression in the endometrium and endometriotic lesions in patients with genital endometriosis, type 1 diabetes mellitus and their comorbidity 2023
- Machine learning-based integrated identification of predictive combined diagnostic biomarkers for endometriosis 2023
- Extracellular vesicle-derived long non-coding RNA as circulating biomarkers for endometriosis 2021
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Androgens, oestrogens and endometrium: a fine balance between perfection and pathology 2020
- Spatial and temporal changes in the expression of steroid hormone receptors in mouse model of endometriosis 2020
- AC002454.1 and CDK6 synergistically promote endometrial cell migration and invasion in endometriosis 2019
- Local estrogen formation and its regulation in endometriosis 2019
- Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis 2018
- Expression Pattern of G-Protein-Coupled Estrogen Receptor in Myometrium of Uteri with and without Adenomyosis 2017
- Are we facing a potential effective treatment for endometriosis? 2015
- Genome-Wide Microarray Analysis of Long Non-Coding RNAs in Eutopic Secretory Endometrium with Endometriosis 2015
- MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? 2015
Source provenance
- europepmc
- last seen: 2026-08-02T06:10:09.037253+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:58.238279+00:00
License: CC0
· commercial use OK